Placing Patients At The Center Of Drug Design

Patient centricity has always been at the heart of the pharmaceutical industry. With rising costs of drugs and healthcare, there has been an increased focus on the topic. Poor patient acceptance and adherence to medications continue to be some of the top challenges facing the healthcare and pharmaceutical industries. Although the reasons for non-adherence are multifactorial, drug developers can bring patient insights into the design of their drug products to potentially improve patient acceptance and adherence.

Experts from Catalent discuss the best time to start thinking about patient centricity during development, the steps developers can take to achieve patient-centric drug design, and how formulation and dosage forms can make a difference for patients.